Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Pharma
Opdivo-maker Ono pays $2.4B for Deciphera
The price tag includes both the approved cancer drug Qinlock and another Deciphera candidate heading to the FDA’s desk in the coming months.
James Waldron
Apr 29, 2024 8:55am
Is AstraZeneca stretching too thin with M&As? CEO says 'no'
Apr 25, 2024 11:09am
Apotex buys specialty drugmaker Searchlight in expansion move
Apr 3, 2024 12:41pm
Novo Nordisk, Actylis ink pact to supply antiseptic in Europe
Mar 25, 2024 10:15am
Indian CDMOs Suven Pharma, Cohance Lifesciences plan merger
Mar 5, 2024 8:30am
Telix moves to acquire CDMO IsoTherapeutics in $13.6M deal
Feb 28, 2024 9:26am